These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16980074)

  • 1. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.
    Basse G; Ribes D; Kamar N; Mehrenberger M; Sallusto F; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2308-10. PubMed ID: 16980074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients.
    Basse G; Ribes D; Kamar N; Mehrenberger M; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
    Transplantation; 2005 Dec; 80(11):1560-4. PubMed ID: 16371926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS; Wong CF
    J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
    Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
    Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
    Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
    Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
    Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S
    Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
    Westphal S; Hansson S; Mjörnstedt L; Mölne J; Swerkersson S; Friman S
    Transplant Proc; 2006 Oct; 38(8):2659-60. PubMed ID: 17098031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Membranoproliferative glomerulonephritis in patients with cryoglobulinemia complicating hepatitis C virus: report of 11 cases].
    Ben Fatma L; Ben Hamida F; Aoudia R; Goucha R; Kaaroud H; Béji S; Barbouch S; Hedri H; Abderrahim E; Elyounsi F; Ben Abdallah T; Ben Moussa F; Kheder A
    Tunis Med; 2007 Mar; 85(3):220-4. PubMed ID: 17668578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft.
    Bestard O; Cruzado JM; Ercilla G; Gomà M; Torras J; Serón D; Rama I; Ibernon M; Viñas O; Carrera M; Grinyó JM
    Nephrol Dial Transplant; 2006 Aug; 21(8):2320-4. PubMed ID: 16751656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
    G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report.
    Sirimongkolrat T; Premasathian N; Vongwiwatana A; Limsrichamrern S; Cheunsuchon B; Vasuvattakul S
    Transplant Proc; 2008 Sep; 40(7):2440-1. PubMed ID: 18790261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal involvement in monoclonal (type I) cryoglobulinemia: two cases associated with IgG3 kappa cryoglobulin.
    Karras A; Noël LH; Droz D; Delansorne D; Saint-André JP; Aucouturier P; Alyanakian MA; Grünfeld JP; Lesavre P
    Am J Kidney Dis; 2002 Nov; 40(5):1091-6. PubMed ID: 12407656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
    Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
    Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
    Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
    Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of symptomatic transplant glomerulopathy with rituximab.
    Rostaing L; Guilbeau-Frugier C; Fort M; Mekhlati L; Kamar N
    Transpl Int; 2009 Sep; 22(9):906-13. PubMed ID: 19453996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
    Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy.
    Quartuccio L; Salvin S; Fabris M; Sacco S; De Vita S
    Ann Rheum Dis; 2008 Oct; 67(10):1494-5. PubMed ID: 18791058
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryoglobulinemia and renal disease.
    Alpers CE; Smith KD
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):243-9. PubMed ID: 18408474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.